prazosin has been researched along with Cardiomyopathy, Congestive in 9 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Short- and long-term hemodynamic and clinical responses to sequential therapy with prazosin (15 mg/day for 3 to 12 weeks) and captopril (75 to 300 mg/day for 2 to 15 weeks) were compared in 22 patients with severe chronic congestive heart failure." | 7.67 | Comparative hemodynamic and clinical effects of long-term treatment with prazosin and captopril for severe chronic congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. ( Medina, N; Packer, M; Yushak, M, 1986) |
| "Short- and long-term hemodynamic and clinical responses to sequential therapy with prazosin (15 mg/day for 3 to 12 weeks) and captopril (75 to 300 mg/day for 2 to 15 weeks) were compared in 22 patients with severe chronic congestive heart failure." | 3.67 | Comparative hemodynamic and clinical effects of long-term treatment with prazosin and captopril for severe chronic congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. ( Medina, N; Packer, M; Yushak, M, 1986) |
| "Treatment with prazosin for one month also reduced systemic vascular resistance by 8%, renal vascular resistance increased by 20%, and renal blood flow and the percentage of the cardiac output going to the kidney fell by 14% and 26%." | 2.66 | The renal response to neuroendocrine inhibition in chronic heart failure: double-blind comparison of captopril and prazosin. ( Bayliss, J; Canepa-Anson, R; Norell, M; Poole-Wilson, P; Sutton, G, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Re, G | 1 |
| Bergamasco, L | 1 |
| Badino, P | 1 |
| Borgarelli, M | 1 |
| Odore, R | 1 |
| Tarducci, A | 1 |
| Zanatta, R | 1 |
| Girardi, C | 1 |
| Steinfath, M | 1 |
| Chen, YY | 1 |
| Lavický, J | 1 |
| Magnussen, O | 1 |
| Nose, M | 1 |
| Rosswag, S | 1 |
| Schmitz, W | 1 |
| Scholz, H | 1 |
| Morozova, TE | 1 |
| Vago, T | 1 |
| Bevilacqua, M | 1 |
| Norbiato, G | 1 |
| Baldi, G | 1 |
| Chebat, E | 1 |
| Bertora, P | 1 |
| Baroldi, G | 1 |
| Accinni, R | 1 |
| Burduli, FU | 1 |
| Khadzhidis, PK | 1 |
| Vatsadze, TG | 1 |
| Tabidze, GA | 1 |
| Grigor'iants, RA | 1 |
| Naumov, VG | 1 |
| Shevliagin, SA | 1 |
| Skvortsov, AA | 1 |
| Mukharliamov, NM | 1 |
| Urbaszek, W | 1 |
| Graf, B | 1 |
| Bölter, C | 1 |
| Zingler, C | 1 |
| Mekat, A | 1 |
| Nabel, HJ | 1 |
| Ernst, B | 1 |
| Packer, M | 1 |
| Medina, N | 1 |
| Yushak, M | 1 |
| Bayliss, J | 1 |
| Canepa-Anson, R | 1 |
| Norell, M | 1 |
| Poole-Wilson, P | 1 |
| Sutton, G | 1 |
2 trials available for prazosin and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
[Use of prazosin and capoten in the treatment of heart failure in patients with ischemic heart disease].
Topics: Adult; Captopril; Cardiomyopathy, Dilated; Clinical Trials as Topic; Coronary Disease; Hemodynamics; | 1989 |
The renal response to neuroendocrine inhibition in chronic heart failure: double-blind comparison of captopril and prazosin.
Topics: Aged; Aldosterone; Captopril; Cardiac Output; Cardiomyopathy, Dilated; Coronary Disease; Double-Blin | 1986 |
7 other studies available for prazosin and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Canine dilated cardiomyopathy: lymphocyte and cardiac alpha(1)- and beta-adrenoceptor concentrations in normal and affected great danes.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cardiomyopathy, Dilated; Catecho | 1999 |
Cardiac alpha 1-adrenoceptor densities in different mammalian species.
Topics: Animals; Binding Sites; Cardiomyopathy, Dilated; Guinea Pigs; Heart Atria; Heart Ventricles; Humans; | 1992 |
[Use of prazosin in the treatment of heart failure in patients with post-infarction cardiosclerosis].
Topics: Adult; Aged; Cardiomyopathy, Dilated; Coronary Artery Disease; Female; Hemodynamics; Humans; Male; M | 1990 |
Identification of alpha 1-adrenergic receptors on sarcolemma from normal subjects and patients with idiopathic dilated cardiomyopathy: characteristics and linkage to GTP-binding protein.
Topics: Adult; Alamethicin; Binding, Competitive; Calcium-Transporting ATPases; Cardiomyopathy, Dilated; Dih | 1989 |
[Use of peripheral vasodilator agents with various mechanisms of action in patients with dilated cardiomyopathy].
Topics: Adult; Captopril; Cardiomyopathy, Dilated; Female; Hemodynamics; Humans; Male; Middle Aged; Nifedipi | 1988 |
[The status of prazosin in therapy of chronic heart failure].
Topics: Cardiomyopathy, Dilated; Coronary Disease; Drug Therapy, Combination; Heart Failure; Heart Valve Dis | 1988 |
Comparative hemodynamic and clinical effects of long-term treatment with prazosin and captopril for severe chronic congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Captopril; Cardiomyopathy, Dilated; Coronary Disease; Female; Heart Failure; Hemodynami | 1986 |